Oscar Health, Inc.
General ticker "OSCR" information:
- Sector: Health Care
- Industry: Medical - Healthcare Plans
- Capitalization: $4.0B (TTM average)
Oscar Health, Inc. follows the US Stock Market performance with the rate: 31.1%.
Estimated limits based on current volatility of 3.1%: low 13.80$, high 14.69$
Factors to consider:
- Total employees count: 2400 as of 2024
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Changes to ACA regulations, Cybersecurity threats, Regulatory and compliance, Medical cost management, Customer retention
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [12.55$, 22.89$]
- 2026-12-31 to 2027-12-31 estimated range: [13.84$, 24.64$]
Financial Metrics affecting the OSCR estimates:
- Negative: with PPE of -8.5 at the end of fiscal year the price was high
- Positive: Operating cash flow per share per price, % of 28.15 > 12.96
- Positive: -4.75 < Operating profit margin, % of -3.28
- Negative: negative Net income
- Positive: -9.07 < Industry operating profit margin (median), % of 0.94
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: -14.22 < Investing cash flow per share per price, % of -6.20
- Positive: -0.01 < Industry operating cash flow per share per price (median), % of 5.10
Short-term OSCR quotes
Long-term OSCR plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $5,862.87MM | $9,177.56MM | $11,701.43MM |
| Operating Expenses | $6,098.48MM | $9,120.30MM | $12,097.78MM |
| Operating Income | $-235.62MM | $57.27MM | $-396.36MM |
| Non-Operating Income | $-31.68MM | $-23.84MM | $-40.94MM |
| Interest Expense | $24.60MM | $23.73MM | $17.60MM |
| Income(Loss) | $-267.30MM | $33.43MM | $-437.30MM |
| Taxes | $3.29MM | $7.30MM | $5.61MM |
| Profit(Loss)* | $-270.73MM | $25.43MM | $-443.15MM |
| Stockholders Equity | $803.97MM | $1,013.59MM | $977.65MM |
| Assets | $3,601.48MM | $4,840.50MM | $6,325.41MM |
| Operating Cash Flow | $-272.16MM | $978.19MM | $1,094.85MM |
| Capital expenditure | $25.58MM | $27.90MM | $36.37MM |
| Investing Cash Flow | $577.19MM | $-1,387.43MM | $-241.06MM |
| Financing Cash Flow | $6.45MM | $68.39MM | $399.21MM |
| Earnings Per Share** | $-1.22 | $0.11 | $-1.69 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.